Quality of Life Within One Year Following Presentation After Transient Loss of Consciousness
Abstract
The purpose of this study was to examine (1) changes in quality of life (QoL) within 1 year after presentation with transient loss of consciousness (TLOC) and (2) which factors are predictive of these changes. This study was part of the Fainting Assessment Study (FAST), which assessed diagnostic strategies in patients with TLOC. Adult patients presenting to Academic Medical Center, Amsterdam, The Netherlands, with TLOC were included in the study. QoL was assessed with the generic Short Form 36 and the disease-specific Syncope Functional Status Questionnaire at presentation and 1 year of follow-up. Of 468 included patients, 82% completed questionnaires at presentation and 72% after 1-year follow-up. QoL improved on 7 of 8 subscales of the Short Form 36 and on all summary scales of the Syncope Functional Status Questionnaire. Older age, recurrence, higher level of co-morbidity, and a neurologic or psychogenic diagnosis were predictive of poorer QoL. In conclusion, QoL in patients with TLOC improves significantly over time. Physicians should particularly pay attention to patients who are older, have recurrent episodes, a neurologic or psychogenic diagnosis, and a higher level of co-morbidity because these patients are vulnerable to a relatively poorer QoL.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the Fainting Assessment Study, general and syncope-specific quality of life improved over a 1-year period.
“In the Fainting Assessment Study (733), general and syncope-specific QoL improved over a 1-year period.”
From 2017 ACC/AHA/HRS Guideline for the Evaluation and Management of Patients With Syncope (2017) · cites this paper as [733]
Quality of life is reduced with recurrent syncope.
“QoL is reduced with recurrent syncope (725–733), as demonstrated in studies that compared patients with and without syncope (727,731).”
From 2017 ACC/AHA/HRS Guideline for the Evaluation and Management of Patients With Syncope (2017) · cites this paper as [733]
Quality of life impairments associated with syncope improve over time.
“QoL impairments associated with syncope improve over time (733).”
From 2017 ACC/AHA/HRS Guideline for the Evaluation and Management of Patients With Syncope (2017) · cites this paper as [733]
Predictors of worse quality of life over time include advanced age, recurrent syncope, neurological or psychogenic reason for syncope, and greater comorbidity at baseline.
“Predictors of worse QoL over time include advanced age, recurrent syncope, neurological or psychogenic reason for syncope, and greater comorbidity at baseline (733).”
From 2017 ACC/AHA/HRS Guideline for the Evaluation and Management of Patients With Syncope (2017) · cites this paper as [733]
Quality of life is reduced with recurrent syncope, as demonstrated in studies that compared patients with and without syncope.
“QoL is reduced with recurrent syncope (397–405), as demonstrated in studies that compared patients with and without syncope (399,405).”
From 2017 ACC/AHA/HRS Guideline for the Evaluation and Management of Patients With Syncope: Executive Summary (2017) · cites this paper as [405]
The citation lists haven’t been fetched yet
References 20 · Cited by 87
- Authors
- van Dijk, N., Sprangers, M. A., Boer, K. R., Colman, N., Wieling, W., & Linzer, M.
- Affiliations
- Amsterdam UMC Location University of Amsterdam (NL)
- University of Wisconsin–Madison (US)
- Venue
- The American Journal of Cardiology
- Publisher
- Elsevier BV
- Published
- 2007-08
- Volume
- 100
- Issue
- 4
- Pages
- 672-676
- ISSN
- 0002-9149 (ISSN-L)
- OpenAlex
- W2032845009
- Cited by
- 87
- References
- 20
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 2 · 2023: 1 · 2022: 4 · 2021: 7 · 2020: 3 · 2019: 6 · 2018: 3 · 2017: 9 · 2016: 3 · 2015: 4 · 2014: 4 · 2013: 9 · 2012: 5
- FWCI
- 6.31
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The American Journal of Cardiology (publishedVersion)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (publishedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Funders
- Medtronic
- Hartstichting
- Topics
- Health Sciences › Medicine › Surgery › Cardiovascular Syncope and Autonomic Disorders
- Health Sciences › Medicine › Psychiatry and Mental health › Psychosomatic Disorders and Their Treatments
- Health Sciences › Medicine › Neurology › Long-Term Effects of COVID-19
- Keywords
- transient loss of consciousness, syncope, quality of life, long-term outcomes, predictors of quality of life, recurrent syncope, psychogenic syncope, comorbidities, aging, Short Form-36
- MeSH terms
- Female, Follow-Up Studies, Humans, Male, Middle Aged, Netherlands, Prognosis, Quality of Life, Surveys and Questionnaires, Recurrence, Retrospective Studies, Risk Factors, Syncope, Time Factors, Incidence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review